Invesco Ltd. purchased a new stake in Invesco Comstock Contrarian Equity ETF (BATS:CSTK – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,925,000 shares of the company’s stock, valued at approximately $106,014,000. Invesco Ltd. owned approximately 99.62% of Invesco Comstock Contrarian Equity ETF as of its most recent SEC filing.
Invesco Comstock Contrarian Equity ETF Trading Down 0.0%
CSTK opened at $28.73 on Wednesday. The stock has a fifty day moving average price of $28.09 and a 200-day moving average price of $27.54. The company has a market cap of $113.21 million and a price-to-earnings ratio of 17.05.
Invesco Comstock Contrarian Equity ETF Company Profile
Read More
- Five stocks we like better than Invesco Comstock Contrarian Equity ETF
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers
- How to Profit From Growth Investing
- 10X Gains? These 3 Robotics Stocks Could Explode by 2035
- How to Use the MarketBeat Stock Screener
- Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers
Receive News & Ratings for Invesco Comstock Contrarian Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Comstock Contrarian Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
